Navigation Links
Maxor Completes Its Acquisition of Pharmaceutical Specialties, Inc. (PSI)

AMARILLO, Texas, Dec. 2, 2016 /PRNewswire/ -- Maxor National Pharmacy Services, LLC ("Maxor"), today announced that it has completed its acquisition of Pharmaceutical Specialties, Inc. ("PSI").  The combination of Texas-based Maxor Specialty / IV Solutions and Georgia-based PSI bring together both company's clinical expertise and high-touch patient service models to provide patients, physicians, manufacturers, and payers an industry-leading specialty pharmacy.

About Maxor

Established in 1926, Maxor is a leading pharmacy services platform that consists of three primary business segments: (i) Maxor Specialty and IV Solutions, providing specialty pharmacy, respiratory, and home infusion services; accredited by the Accreditation Commission for Health Care and by The Joint Commission, respectively; (ii) MaxorPlus, providing client and patient-focused URAC accredited pharmacy benefit management (PBM) services with desired clinical outcomes; and (iii) Maxor Pharmacy Management and Consulting Services, providing on-site outpatient pharmacy management, 340B audits, and consulting services to hospitals, health systems, Federally Qualified Health Plans, DSH hospitals, and self-funded employer groups.

These segments offer complementary services that aim to improve the health of patients and efficiently manage pharmacy expenditures for Maxor's patients and clients. More information on Maxor can be found by visiting

About PSI

Pharmaceutical Specialties, Inc. is a leading pharmacy specializing in pulmonary medicine including cystic fibrosis and bronchiectasis, endocrine therapies including growth hormone, and GI medicine including Hepatitis C and Crohn's disease.

Logo -


To view the original version on PR Newswire, visit:

SOURCE Maxor National Pharmacy Services, LLC
Copyright©2016 PR Newswire.
All rights reserved

Related medicine technology :

1. Maxor National Pharmacy CEO to Retire in 2016
2. Neurotrope Completes Enrollment in its Randomized, Double-Blinded, Placebo-Controlled Phase 2 Clinical Trial of Bryostatin in Patients With Moderate to Severe Alzheimers Disease
3. Amarantus Completes Sale of Diagnostics Division, Announces Fiscal Year 2015 and First Quarter 2016 Financial Results
4. Diplomat Completes Acquisition of TNH Advanced Specialty Pharmacy
5. Impulse Dynamics Completes $30 Million Financing Round
6. Rx-360 Completes Training Workshops in Africa Covering Good Distribution Practices
7. Valeritas Completes Alternative Public Offering and Raises Gross Proceeds of $25.2 Million
8. Pats Run: Tin Man Completes 3rd Consecutive Run Without His Native Heart
9. TapImmune Completes GMP Manufacturing and Release of TPIV 200 Vaccine
10. Oramed Completes Phase IIb Oral Insulin Study
11. Arterys Completes Series A Financing
Post Your Comments:
(Date:11/21/2019)... BEVERLY HILLS, Calif. (PRWEB) , ... November 20, 2019 , ... The Lifedriven Foundation along ... its Mixing it Up with the Champs event from 8 to 11 p.m. on Friday, ... Vegas. This fundraising event will take place on the eve of the PBC Heavyweight Title ...
(Date:11/20/2019)... ... November 20, 2019 , ... “Analysis of the Biofield ... Assay” by Maria Isabel Aguilar has been named No. 1 International Best Seller ... Research, Holistic, Mind-Body Medicine, Allied Health Professions, and Energy Healing. , The aim ...
(Date:11/19/2019)... ... ... “Protective Role of the Biofield Energy Treated Test Formulation on Vital Organs ... Best Seller on Amazon in the USA, Canada, and United Kingdom in 19 categories ... named a hot new release in multiple categories in the USA, Canada, and United ...
Breaking Medicine Technology:
(Date:11/21/2019)... , ... November 21, 2019 , ... ...; 860-515-3889 , Middlesex Health Care Awarded the Golden Acorn by the Charter ... , The Foundation for Charter Oak State College, Connecticut’s public online college, recently ...
(Date:11/21/2019)... ... November 21, 2019 , ... PointClickCare, ... post-acute care and senior care industry, has named Richter as its 2019 ... Richter and PointClickCare on targeted training activities related to Medicare Patient-Driven Payment ...
(Date:11/20/2019)... ... November 20, 2019 , ... Fujirebio ... and Drug Administration (FDA) clearance of the company’s Lumipulse® G whole PTH Assay ... a hormone secreted by the parathyroid glands; which are four small glands located ...
(Date:11/20/2019)... , ... November 20, 2019 , ... ... Health Specific Biomarkers Using Cell Line Study” by Ariadne Esmene Afaganis has been ... Kingdom in many categories including Nervous System, Molecular Biology, Energy Healing, Public Health, ...
(Date:11/19/2019)... (PRWEB) , ... November 19, 2019 , ... It was ... marathon with a bike ride along the Charles River in Boston. Days later, Bernie ... to him, yet he struggled to know exactly who all of them were. For ...
Breaking Medicine News(10 mins):